24 May 2013
Keywords: s-p, initiate, ph, iii, boceprevir, program, drug
Article | 02 June 2008
US drug major Schering-Plough has announced plans to initiate two large-scale Phase III studies of its investigational oral hepatitis C
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 June 2008
23 May 2013
© 2013 thepharmaletter.com